ZURICH, April 24 (Reuters) - Swiss stocks were seen opening slightly higher on Thursday, in line with European markets supported by good results from Apple and Facebook .
ZURICH, April 24 (Reuters) - Exports from Switzerland rose by a real 5.1 percent in March to 17.35 billion Swiss francs, the Federal Customs Office said on Thursday.
Kanak Kanti De : A major blow was dealt to companies working on RNA therapeutics, when Fierce Biotech broke the news that the Swiss giant, Novartis was getting out of the technology. This was the second instance of Big Pharma showing lack of confidence in
U.S.-based firms make up almost 51% of this ETF's assets, followed by British companies (14.5% of assets), Swiss firms (7.5%), Japanese companies (5.5%), and French companies (4.5%). Suitability Investors seeking exposure
BRUSSELS, April 23 (Reuters) - The European Commission said on Wednesday it is investigating plans by Mexican cement company Cemex to buy the Spanish operations of its Swiss rival Holcim because of...
* Founders plan to sell a further 4.9 mln existing shares
ZURICH, April 23 (Reuters) - Swiss stocks were seen opening a tough higher on Wednesday, as investors await manufacturing data for France, Germany and the euro zone.
ZURICH, April 23 (Reuters) - Swiss engineering components firm SFS said it seeks to raise as much as 349 million Swiss francs ($394.08 million) by issuing new shares when it lists on the Swiss bourse next month.
markets, and there are not many flat or inverted yield curves around the world. However, with the exception of Japan and Switzerland , the emerging markets are home to all the world’s flat or inverted yield curves* (see Chart 2). Thus, the liquidity
ZURICH, April 22 (Reuters) - Novartis believes GlaxoSmithKline's cancer drugs Votrient, Tafinlar and Mekinist could have more than $1 billion in sales each, the head of the Swiss company's pharmaceutical unit said on Tuesday.